Neuronetics, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $1.28
- 52-Week Range
- $0.80 – $3.44
- Market Cap
- $120.60M
- P/E (TTM)
- —
- EPS (TTM)
- -0.32
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 5.19
- PEG Ratio
- —
- Return on Equity
- -85.58%
- Return on Assets
- -6.58%
- Gross Margin
- 50.93%
- Operating Margin
- -9.14%
- Profit Margin
- -14.45%
- Current Ratio
- 2.01
- Debt/Equity
- 3.92
- Total Debt
- $87.73M
- Free Cash Flow
- $-4.65M
- Revenue Growth
- 12.50%
- Earnings Growth
- —
- Enterprise Value
- $166.48M
Market Snapshot
About
Neuronetics, Inc. is a commercial-stage medical technology company focused on non-invasive treatments for psychiatric disorders. The company develops and markets the NeuroStar Advanced Therapy system, a transcranial magnetic stimulation device for treating major depressive disorder and other mental health conditions.